KM
Karen McLoughlin
Director

Karen McLoughlin insider trades: agilon health (AGL) stock buys and sales

Director, agilon health Last trade Dec 13, 2024 157 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
55
Open-market trades
since 2012
3
Companies
last trade 2024

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Karen reports to the SEC

Open-market buys and sales

55 trades reported on SEC Form 4, newest first

DateStockTypeValue
Dec 13, 2024AGL↑ Buy$55K
Feb 5, 2020CTSH↓ Sell$72K
Feb 4, 2020CTSH↓ Sell$46K
Jan 16, 2020CTSH↓ Sell$1.1M
Dec 17, 2019CTSH↓ Sell$20K
Dec 6, 2019CTSH↓ Sell$62K
Sep 11, 2019CTSH↓ Sell$99K
Sep 6, 2019CTSH↓ Sell$64K
Jul 9, 2019CTSH↓ Sell$508K
Jun 24, 2019CTSH↓ Sell$20K
Jun 11, 2019CTSH↓ Sell$97K
Jun 10, 2019CTSH↓ Sell$94K
Jul 12, 2018CTSH↓ Sell$409K
Jun 8, 2018CTSH↓ Sell$107K
Mar 15, 2018CTSH↓ Sell$150K
Jan 16, 2018CTSH↓ Sell$942K
Dec 7, 2017CTSH↓ Sell$1.0M
Nov 30, 2017CTSH↓ Sell$685K
Feb 23, 2017CTSH↓ Sell10b5-1$294K
Dec 9, 2016CTSH↓ Sell10b5-1$1.1M
Nov 28, 2016CTSH↓ Sell10b5-1$109K
Nov 1, 2016CTSH↓ Sell10b5-1$513K
Aug 5, 2016CTSH↓ Sell10b5-1$1.2M
Jun 20, 2016CTSH↓ Sell10b5-1$490K
Jun 10, 2016CTSH↓ Sell10b5-1$36K
Jun 8, 2016CTSH↓ Sell10b5-1$102K
Apr 7, 2016CTSH↓ Sell10b5-1$54K
Mar 30, 2016CTSH↓ Sell10b5-1$103K
Sep 9, 2015CTSH↓ Sell10b5-1$89K
Aug 5, 2015CTSH↓ Sell10b5-1$348K
Jun 12, 2015CTSH↓ Sell$319K
May 4, 2015CTSH↓ Sell10b5-1$650K
Mar 18, 2015CTSH↓ Sell10b5-1$117K
Feb 12, 2015CTSH↓ Sell10b5-1$600K
Dec 23, 2014CTSH↓ Sell10b5-1$76K
Dec 19, 2014CTSH↓ Sell10b5-1$90K
Dec 15, 2014CTSH↓ Sell10b5-1$51K
Jun 17, 2014CTSH↓ Sell10b5-1$388K
Jun 6, 2014CTSH↓ Sell10b5-1$40K
May 6, 2014CTSH↓ Sell10b5-1$49K
Mar 7, 2014CTSH↓ Sell10b5-1$59K
Feb 24, 2014CTSH↓ Sell10b5-1$525K
Feb 7, 2014CTSH↓ Sell10b5-1$62K
Dec 6, 2013CTSH↓ Sell10b5-1$38K
Nov 27, 2013CTSH↓ Sell10b5-1$475K
Nov 6, 2013CTSH↓ Sell10b5-1$59K
Sep 18, 2013CTSH↓ Sell10b5-1$43K
Sep 11, 2013CTSH↓ Sell10b5-1$96K
Aug 13, 2013CTSH↓ Sell10b5-1$48K
Aug 6, 2013CTSH↓ Sell10b5-1$91K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other AGL insiders

Open-market trades in the last 12 months

About Karen McLoughlin's insider trades

Karen McLoughlin is a director at agilon health (AGL). Since Feb 7, 2012, Karen has reported 1 open-market purchase worth $55K and 54 sales worth $14.1M on SEC Form 4. There have been no open-market trades in the last 12 months.

36 sales (59% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.

Their filings also include option exercises (81 filings), shares withheld for taxes (72 filings), grants and awards (32 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AGL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.